Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2010

View Archived Issues

EVX-001688 improves spatial memory in young and aged rats

Phase Ia trial demonstrates safety of SGN-70 in healthy subjects

GRN-529 has antidepressant, anxiolytic and analgesic effects in vivo

Boehringer Ingelheim describes novel mTOR inhibitors

FDA clears Advanced Cell Technology's phase I/II RPE trial

NeuroSearch claims new activators of voltage-gated K(V)7.2/3 potassium channel

SkyePharma advances two phase III trials of asthma candidate Flutiform in Japan

BMS-582949 shows promise to treat rheumatoid arthritis

LCZ-696 is well tolerated by patients with chronic stable heart failure in phase II trial

First-in-human data disclosed on dual PI3K/mTOR inhibitors PF-05212384 and PF-04691502

FG-4592 is safe and increases hemoglobin levels in CKD-related anemia

Roche to develop diagnostic tests to detect EGFR mutations in lung cancer

Abbott patents new serotonin 5-HT2C receptor agonists

Pivotal phase III trial of IPX-066 in early PD meets primary endpoint

Baxter and Archemix enter into agreements covering hemophilia-related assets

GW and Otsuka Pharma begin phase III cancer pain program for Sativex

Achaogen claims novel carbacephem beta-lactam antibiotics

GlaxoSmithKline discloses new orexin receptor antagonists

CEL-SCI completes global investigator meeting on phase III Multikine trial

Gilead submits NDA to FDA for single-tablet Truvada/TMC-278 combination

Vertex Pharma submits NDA to FDA for telaprevir in hepatitis C

FDA approves testosterone replacement therapy Axiron

Grifols launches Flebogamma 10% DIF in U.S.

SIRS-Lab and Pfizer collaborate on diagnostic tests to benefit patients with sepsis

Gablofen injection approved in U.S. for severe spasticity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...